PeptiDream Inc. (PPTDF)
OTCMKTS · Delayed Price · Currency is USD
11.10
0.00 (0.00%)
Oct 21, 2025, 8:00 PM EDT
PeptiDream Revenue
PeptiDream had revenue of 4.31B JPY in the quarter ending June 30, 2025, a decrease of -86.49%. This brings the company's revenue in the last twelve months to 19.09B, down -65.56% year-over-year. In the year 2024, PeptiDream had annual revenue of 46.68B with 62.57% growth.
Revenue (ttm)
19.09B JPY
Revenue Growth
-65.56%
P/S Ratio
10.68
Revenue / Employee
30.73M JPY
Employees
621
Market Cap
1.41B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.68B | 17.96B | 62.57% |
| Dec 31, 2023 | 28.71B | 1.86B | 6.93% |
| Dec 31, 2022 | 26.85B | 17.49B | 186.70% |
| Dec 31, 2021 | 9.37B | -2.31B | -19.79% |
| Dec 31, 2020 | 11.68B | 9.60B | 462.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |